ArticleDrug and alcohol review2026
Prevalence, Associations and Comorbidity of Cannabis Use and Cannabis Use Disorders in the Australian National Mental Health Surveys From 2007 to 2020-22.
Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unusually Large Effect Sizes and Confidence Intervals: Too Big to be True?Drug and alcohol review · 2026Article
- Confusing Uncertainty With Bias: The Challenges of Working With Real-World Data.Drug and alcohol review · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
introductionAs cannabis policies become more liberal, and products increasingly potent, it is important to monitor changes in rates of cannabis use and those at risk of harm. We used data from the largest national mental health survey in Australia to examine changes in prevalence, associations and comorbidity of past 12-month cannabis use and cannabis use disorder (CUD) from 2007 to 2020-22.
methodsData were drawn from the two most recent Australian National Surveys of Mental Health and Wellbeing (age range: 16-85): 2007 (n = 8841) and 2020-22 (n = 15,893). The prevalence of use and CUD were estimated and logistic regression was used to examine associations between individual characteristics and cannabis use outcomes, as well as changes in strength of association over time.
resultsPrevalence of recent cannabis use was stable from 2007 (6.7%, 95% CI 6.0%, 7.3%) to 2020-22 (6.7%, 95% CI 6.2%, 7.1%), as was CUD (1.0%, 95% CI 0.7%, 1.3%; 0.6%, 95% CI 0.4%, 0.8%). Respondents were significantly more likely to report CUD if they were younger (16-25 years), male, initiated cannabis use < 18 years, reported recent polysubstance use, exhibited other substance and mental disorders and had visited mental health services (OR 3.26-78.00). Compared to 2007, the association between younger age and CUD was stronger in 2020-22 (OR 2.39, 95% CI 1.20, 4.77), whereas the association between polysubstance use and CUD was weaker (OR 0.42, 95% CI 0.20, 0.91). DISCUSSION AND
conclusionsFindings suggest that population-level use and CUD may have remained stable over time, but young people may now be more vulnerable to developing CUD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.